Evidence map›Paper›PMID 21568272›Full record

ArticleChemical research in toxicology2011

(--)-Xanthatin selectively induces GADD45γ and stimulates caspase-independent cell death in human breast cancer MDA-MB-231 cells.

Shuso Takeda, Kazumasa Matsuo, Kentaro Yaji, Shunsuke Okajima-Miyazaki, Mari Harada, Hiroko Miyoshi, Yoshiko Okamoto, Toshiaki Amamoto, Mitsuru Shindo, Curtis J Omiecinski and 1 more

Abstract read
In one paragraph

Article in Chemical research in toxicology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 37 citations in OpenAlex.

  1. Review
  2. Review
  3. Phytochemical analysis and antioxidant, antimicrobial, and cytotoxic activities ofTurkish journal of biology = Turk biyoloji dergisi · 2025
    Article
  4. A Study Against Colon Cancer Mechanism ofCombinatorial chemistry & high throughput screening · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. GADD45 proteins: central players in tumorigenesis.Current molecular medicine · 2012
    Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Shuso TakedaDepartment of Molecular Biology, Daiichi University of Pharmacy, 22-1 Tamagawa-cho, Minami-ku, Fukuoka 815-8511, Japan.
Kazumasa Matsuo
Kentaro Yaji
Shunsuke Okajima-Miyazaki
Mari Harada
Hiroko Miyoshi
Yoshiko Okamoto
Toshiaki Amamoto
Mitsuru Shindo
Curtis J Omiecinski
Hironori Aramaki
Daiichi University of Pharmacy · JPKyushu University · JPPennsylvania State University · US

Funding

Interindividual Variability in Human Microsomal Epoxide HydrolaseR01ES016358 · NIEHS · PENNSYLVANIA STATE UNIVERSITY, THE · PI OMIECINSKI, CURTIS J · 2009 to 2012
$1.3M
NIEHS NIH HHS R01 ES016358
6 · The paper itself

Abstract

exo-Methylene lactone group-containing compounds, such as (--)-xanthatin, are present in a large variety of biologically active natural products, including extracts of Xanthium strumarium (Cocklebur). These substances are reported to possess diverse functional activities, exhibiting anti-inflammatory, antimalarial, and anticancer potential. In this study, we synthesized six structurally related xanthanolides containing exo-methylene lactone moieties, including (--)-xanthatin and (+)-8-epi-xanthatin, and examined the effects of these chemically defined substances on the highly aggressive and farnesyltransferase inhibitor (FTI)-resistant MDA-MB-231 cancer cell line. The results obtained demonstrate that (--)-xanthatin was a highly effective inhibitor of MDA-MB-231 cell growth, inducing caspase-independent cell death, and that these effects were independent of FTase inhibition. Further, our results show that among the GADD45 isoforms, GADD45γ was selectively induced by (--)-xanthatin and that GADD45γ-primed JNK and p38 signaling pathways are, at least in part, involved in mediating the growth inhibition and potential anticancer activities of this agent. Given that GADD45γ is becoming increasingly recognized for its tumor suppressor function, the results presented here suggest the novel possibility that (--)-xanthatin may have therapeutic value as a selective inducer of GADD45γ in human cancer cells, in particular in FTI-resistant aggressive breast cancers.

Indexed as

Antineoplastic Agents, PhytogenicBreast NeoplasmsCaspasesCell CycleCell DeathCell Line, TumorCell ProliferationDNA Topoisomerases, Type IFemaleFuransGADD45 ProteinsGene Expression Regulation, NeoplasticHeme Oxygenase-1HumansInterleukin-18Intracellular Signaling Peptides and ProteinsAntineoplastic Agents, PhytogenicCaspasesDNA Topoisomerases, Type IFuransGADD45 ProteinsHeme Oxygenase-1HMOX1 protein, humanInterleukin-18Intracellular Signaling Peptides and Proteinsxanthatin

Identifiers

PMID21568272
PMCPMC4089510
OpenAlexW2062172999

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.